China NMPA Product Recall - Creatine kinase assay kit (colorimetric method)

The National Medical Products Administration (NMPA) has published details concerning a voluntary Class II recall initiated by Roche Diagnostics GmbH for its Creatine Kinase Assay Kit (Colorimetric Method), registered under National Medical Device Registration Certificate No. 20152403262. This action, reported by Roche Diagnostics Products (Shanghai) Co., Ltd., addresses issues such as abnormal calibration signals identified in specific product batches. The primary concern is the potential impact on the accuracy of diagnostic results due to these calibration irregularities. Roche Diagnostics GmbH, the manufacturer, is undertaking this recall as a proactive measure. Notably, the specific affected batches of this diagnostic kit were not imported into the Chinese market, indicating that the recall efforts are concentrated on other regions, such as the United States, where the products were distributed. Comprehensive information detailing the specific models, specifications, and batch numbers involved is available in the accompanying Medical Device Report Form. This voluntary recall underscores the manufacturer's commitment to product quality and patient safety, addressing identified issues to prevent potential adverse health consequences.